DISCLOSEDQuarterly
Soros Fund Management
Esperion Therapeutics Inc Ne · US
757,358 sh · $2.4M
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$31.0M
13,983,662 sh
Two Sigma Investments
13F filer
$25.9M
9,458,779 sh
Renaissance Technologies
13F filer
$4.4M
1,620,100 sh
Soros Fund Management
13F filer
$2.4M
757,358 sh
Polen Capital Management
13F filer
$430.3K
116,292 sh
Soros Fund Management
Esperion Therapeutics Inc Ne · US
757,358 sh · $2.4M
Two Sigma Investments
Esperion Therapeutics Inc Ne · US
9,458,779 sh · $25.9M
Renaissance Technologies
Esperion Therapeutics Inc Ne · US
1,620,100 sh · $4.4M
Polen Capital Management
Esperion Therapeutics Inc Ne · US
116,292 sh · $430.3K
BlackRock
Esperion Therapeutics Inc Ne · US
13,983,662 sh · $31.0M